chrisvoncsefalvay/vaers-outcomes huggingface dataset:
VACCINE GIVEN AT APPROXIMATELY 12:40. AFTER 15 MINUTE MONITORING PERIOD, PATIENT WAS ASKED BY MONITOR IF SHE WAS FEELING OKAY. PATIENT REPORTS SHE DOES NOT FEEL THE SAME AS BEFORE THE VACCINE. MONITOR STATES PATIENT WAS SHAKING AND HAD NOT PLACED ARM BACK IN SLEEVE FROM INJECTION 15 MINUTES PRIOR. MONITOR IMMEDIATELY GETS  NURSE TO ASSESS PATIENT. AT 1257 BLOOD PRESSURE IS 122/62 AND HEART RATE IS 62. PATIENT REPORTS TO NURSE THAT HER HEAD FEELS FULL AND HER EYES ARE HEAVY. DENIES ANY OTHER SIGNS OR SYMPTOMS. PATIENT STATES SHE IS READY TO LEAVE. NURSES ADVISE PATIENT RECOMMENDATIONS TO BE EVALUATED BY EMS. PATIENT REFUSES STATING SHE WILL NOT WAIT. SHE STATES SHE IS READY TO GO HOME AND IF SHE FEELS BAD WHILE DRIVING SHE WILL PULL OVER. RISKS OF LEAVING AGAIN DISCUSSED WITH PATIENT. SHE ONCE AGAIN REFUSES TO WAIT ANY LONGER AND LEAVES.
SWOLLEN LYMPH NODE UNDER LEFT ARM WHERE VACCINE WAS GIVEN.  ARM VERY SORE AND FEEL PULLING FROM SHOULDER TO ELBOW FROM ARMPIT.
Within 10 minutes of vaccination patient stated they felt short of breath, had a headache, respiratory issues (cough, congestion) and swelling of face and tongue. They developed diarrhea over the weekend. Patient went to see dr on Monday 11/20/23  to receive a nebulizer treatment and steroid shot.
BELLS PALSY RE-EMERGENCE; IMPAIRED CLOSURE OF EYELID, IMPAIRED  ABILITY TO RAISE EYBROW, INABILITY TO SMILE, ALL FACIAL MANIFESTATIONS OF BELLS PALSY
Cellulitis in left foot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CELLULITIS (Cellulitis in left foot) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Surgery (on left foot).    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. In March 2021, the patient experienced CELLULITIS (Cellulitis in left foot) (seriousness criteria hospitalization and medically significant). The patient was hospitalized from sometime in March 2021 to 29-Mar-2021 due to CELLULITIS. At the time of the report, CELLULITIS (Cellulitis in left foot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment medications included unspecified antibiotics.  Daughter did not believe that the cellulitis was related to the vaccine because her mother also had surgery on the same foot.  Company comment:Limited information regarding the event has been provided at this time and a causal relationship cannot be excluded; Sender's Comments: Limited information regarding the event has been provided at this time and a causal relationship cannot be excluded
48-72hours after the patient had low grade fever, headache, swollen arm at injection site, and welps on upper back and shoulder
Gave an inadvertent (accidental) second dose of MMRV (PROQUAD), at about 10 AM on 8/19/14, that was meant for her twin. (Called Merck -> they are researching it via their medical team).
Arm pain & tenderness, fever, chills, n/v, diarrhea. Admitted and cellulitis treated with Septra. Discharge w/ Septra & readmitted for severe Septra allergy-rash, dehydration, n/v.  Was treated and discharged on 5/18. Has been seen by neurology for continued muscle weakness, slowness of speech. Workup pending.
Patient received high dose fluzone even though she is under 65.  At this time she does not have any side effects
Patient states she vomited, felt dizzy and SOB. Pain in the stomach and at injection site.
Fifteen minutes after patient received Hep A, mom reports spots on face, facial swelling and redness. Symptoms lasted one hour. Mom gave Benadryl and took patient to the Emergency Room. No other interventions were done.
Cough; congestion/stuffed nose; runny nose; chills; sore arm; decreased sense of smell; decreased sense of taste; This is a spontaneous report from a contactable physician. A 49-year-old female patient receive first dose of bnt162b2 (BNT162B2), intramuscular on left arm on 17Dec2020 10:15 SINGLE DOSE for COVID-19 immunization. Medical history included Cough variant of asthma, prediabetes. The patient's concomitant medications were not reported. On 18Dec2020 10:00, the patient experienced Cough, congestion, runny nose, chills, sore arm, stuffed nose, decreased sense of smell, decreased sense of taste. No COVID prior vaccination. The patient has been tested for COVID-19 post vaccination. The patient underwent lab tests and procedures which included nasal swab test: pending on 21Dec2020. The outcome of the events was recovering.
Daughter experienced diarrhea; Nausea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Daughter experienced diarrhea), NAUSEA (Nausea) and CHILLS (Chills) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and D37K20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Doctor refused to test people. Hence, she did not have a positive test) in March 2020.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Daughter experienced diarrhea), NAUSEA (Nausea) and CHILLS (Chills). At the time of the report, DIARRHOEA (Daughter experienced diarrhea), NAUSEA (Nausea) and CHILLS (Chills) had resolved.            No Concomitant product use was reported.  The reporter stated that their daughter who was the patient had reactions to the second dose of the Moderna Covid-19 vaccine. The reporter said that the patient experienced diarrhea, nausea, and chills and this lasted around 7 weeks when the patient received the second dose of the Moderna Covid 19 vaccine.  The reporter also stated that the patient had Covid-19 in Mar-2020, but doctor refused to test people and for this reason, the patient did not have a positive test. Reportedly, the patient had no allergies.  No treatment information was provided.   This case was linked to MOD-2022-534407 (Patient Link).
Received Varicella vaccine 4/26/07. On 4/27/07 left arm red and swollen. Seen on 5/1/07 swelling and redness subsiding. Received Benadryl was seen 4/26/07 for nausea and abd. pain and diarrhea. 5/1/07 No more diarrhea, still c/o nausea and stomach pain.
24 hours after the booster, I had a red rash on my face and neck.  I then began going anaphylactic, as my throat was closing and I felt like I was going to pass out.  I quickly epi penned, telling my husband we needed to go to the ER.  We began driving to the ER, and within 10-15 min, I went anaphylactic again.  So, I epi penned again.  We arrived at the ER in about 10 minutes, and I was going anaphylactic again.  I instantly had a team, where they took off my clothes, attached me to a heart monitor and began administering a steroid.  The steroid began to reverse the anaphylactic response.  I stayed in the ER from 3pm to 9:30pm, and asked to leave due to some unsafe conditions in the ER.  I experienced several panic attacks the next 2 days.
Within 1 hour of vaccination, left arm became swollen, red, and warm to touch. Pt brought in following day. It appeared the same. Mom treated with ice, Motrin/Tylenol.
Patient's L arm became very sore the day after she got the shot.  She became itchy all over her the body the next day. She took benedryl for the itching and it stopped but the arm soreness never did go away, even though approximately two weeks have lapsed since she got the shot.She stated that she has been getting the flu shots for many years and has never had a reaction before.
pt was feeling strange tuesday morning. He wouldn't eat but his wife made him drink. By Wednesday morning he couldn't answer questions about the day, who wife was, and couldn't identify himself in a picture. At that point his wife called the ambulance. He was hospitalized there. He was given the Covid test Wednesday.
Cellulitis on chest; Swollen; Tender; Red; Chills; Fever; A spontaneous report was received from a consumer concerning a 96 Years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced cellulitis, fever, chills and injection site swelling, tenderness, and redness.  The patient's medical history included serving as an employee, episodes of days with fever, feeding tube, Pulmonary issues and cellulitis on arm.. Concomitant medication included triamcinolone acetonide cream 0.1%, Tessalon and Robitussin.    On 03 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 030M20A) in his left arm for prophylaxis of COVID-19 infection.  On an undisclosed date, the patient experienced injection site swelling, tenderness, and redness.  On 24 Feb 2021, the patient experienced chills. Vital signs included a temperature of 103.9 degrees Fahrenheit.  Also, his sputum had some blood in it.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events was unknown.; Reporter's Comments: Based on the current available information, a temporal association between the use of the product and the start date of the event and excluding all other etiologies, a causal relationship with the events cannot be excluded. Fever, chills injection site swelling, tenderness and redness are consistent with the known safety profile of the mRNA-1273 vaccine.
One day post vaccination, the pt was seen by the Dr for redness, severe pain, warmth and swelling of the left deltoid. There was an appearance of a band around the area. She was placed on Keflex and responded well.
An expired vaccine was given out 04-Aug-2023 (today)/ expired dose was given; vial was stored in the fridge post puncture; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (An expired vaccine was given out 04-Aug-2023 (today)/ expired dose was given), PRODUCT STORAGE ERROR (vial was stored in the fridge post puncture) and NO ADVERSE EVENT (No adverse event) in a 76-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7645B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 04-Aug-2023 at 10:15 AM, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 04-Aug-2023, the patient experienced NO ADVERSE EVENT (No adverse event). On 04-Aug-2023 at 10:15 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (An expired vaccine was given out 04-Aug-2023 (today)/ expired dose was given) and PRODUCT STORAGE ERROR (vial was stored in the fridge post puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (An expired vaccine was given out 04-Aug-2023 (today)/ expired dose was given), PRODUCT STORAGE ERROR (vial was stored in the fridge post puncture) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (An expired vaccine was given out 04-Aug-2023 (today)/ expired dose was given) and PRODUCT STORAGE ERROR (vial was stored in the fridge post puncture).    Concomitant medication was not provided. Treatment information was not reported.  Open vaccine was given three days after being opened. Refrigerated temperature 30.7 F. Vial size was reported as 2.5 ml. The vial was initially stored in the refrigerator on 27-Jul-2023. Vial was first punctured on 1-Aug-2023. Vaccine was administered on 4-Aug-2023 around 10:15 AM. Vial did not undergo any temperature excursion.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2023: Live follow-up received and updated reporter details, event verbatim (Expired vaccine used). Vaccine related details added.
On 11/22/21 we gave a 17 year old a Pfizer booster, which is only approved for 18+. After getting ahold of the mother on 11/24, she explained that she thought her daughter was immunocompromised. Based on her conditions/meds, the dose should not have been given.
Numbness in face and lips. Some tingling.  Rapid heartbeat.  Normal breathing
Cerebral venous sinus thrombosis with venous infarct.  Was also found to have antithrombin III deficiency and elevated factor 8.  She had uncontrolled HTN and DM at the time and untreated OSA.
CLIENT STATES LEFT ARM CONTINUES TO HURT AFTER RECEIVING FLU VACCINE IN OCTOBER.  STATES THE ARM IS NOT RED BUT THROBS, TENDER TO TOUCH AND PAINFUL ON MOVEMENT.
Severe headaches; Hives; Muscle pain; Joint pain; Chills; Sight tightness in throat; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th August 2021, the patient received the 1st dose of Shingrix. In August 2021, less than a week after receiving Shingrix, the patient experienced headache, hives, muscle pain, joint pain, chills and throat tightness. On an unknown date, the outcome of the headache, hives, muscle pain, joint pain, chills and throat tightness were not recovered/not resolved.   It was unknown if the reporter considered the headache, hives, muscle pain, joint pain, chills and throat tightness to be related to Shingrix.  Additional details provided were as follows: The case was reported by patient himself/herself. Age at vaccination was not reported. The patient received a dose of Shingrix and experienced severe headaches, hives, muscle and joint pain, chills and a slight tightness in the throat. The patient asked if he/she should get the second shot and when it is due. Follow-up would not be possible as no contact details available.
Patient called at 7:20 am on 07/23/14 indicating the injection site was red, warm, raised and itchy. The injection side was 2 inches wide and 3 inches long. Her eyes were also itchy. Symptoms were resolving within 24 hours of onset.
Sudden onset deafness in (R) ear on 12/3/14. Saw Dr. on 12/4/14: started prednisone on 12/4/14 and antiviral (acyclovir) on 12/4/14.
fever; body aches; chills; sore throat; earache; achy joints; right arm where the injection was given is swollen to the elbow; right arm where the injection was given is swollen to the elbow; migraine; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in right arm on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced fever, body aches, chills, sore throat, earache, and achy joints all over, all on an unspecified date. Her right arm where the injection was given was swollen to the elbow and she had a migraine, as well, on an unspecified date. She did not have this kind of reaction to the first dose of the vaccine. The outcome of the events was unknown.   Information about lot/batch number has been requested.
Date of vaccine 4/5/2021.  Date of adverse event:  4/15/2021 acute onset of worst headache of life and imaging consistent w/ subarachnoid hemorrhage likely from rupture of anterior communicating artery rupture.   She was seen in ER and transferred to Hospital and is admitted, awaiting cerebral angiography.  Has not had an intervention.  Available records will be faxed today to your fax number listed.
1st dose administered on 5Apr2021, 2nd on 19Apri2021; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number 7F94C, expiry date 11th November 2022) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 19th April 2021, the patient received the 2nd dose of Shingrix. On 19th April 2021, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The patient received 1st dose of Shingrix on 5th April 2021. The practice manager reported that, the patient received 2nd dose early than the recommended time interval, which led to shortening of vaccination schedule. The reporter consented to follow up.
Following vaccine debilitating migraine that lasted 4 days, felt like head would explode and foggy for about two weeks-this was the short term side effect. Initially, felt pain by injection sight. Eventually it spread and felt shocks in both right and left shoulder joints when reaching for items and sudden movements. The right shoulder is frozen, and the left is a little frozen, can move it up more than the right hand. Extreme constant radiating pain, tingling and muscle weakness in both arms and shoulders and sometimes radiating to upper back and neck when exerting shoulder muscles. Pain is worse at night, need constant hand movement or extremely sore, inflammation and possible nerve damage. Orthopedics took X-rays and MRI, currently on Meloxicam and Cyclobezaprine for several months. Also, saw a Neurologist who recommended Cymbalta for the nerve pain. Will see a Rheumtologist on 11/19 . Did not have any pain previous ta vaccine
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter (Consumer or other non-HCP). The reporter is the patient.  A 59-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Oct2022 as DOSE 5 (BOOSTER), SINGLE (batch/lot number: unknown) at the age of 59 years old, administered in the left arm for COVID-19 immunization; Covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (batch/lot number: unknown), as dose 2, single (batch/lot number: uknown), as dose 3 (booster), single (batch/lot number: unknown) and as dose 4 (booster), single (batch/lot number: unknown) for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The patient had no known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Feb2023, outcome "unknown" and all described as "COVID 19 Treatment." The patient underwent the following laboratory tests and procedures: Covid-19 Test (SARS-CoV-2 test): (Feb2023) Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of Drug ineffective, Covid-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Patient's mother provided our clinic with the patient's vaccine records ~1 week prior to appointment. The medical assistant (MA) reviewed the record and checked it in immunization system, but because patient came from another state there was no record in here. The MA prepared the vaccines after the doctor ordered them according to the vaccine record that was provided by the mother. One of these that was noted was that the patient had not yet received a Hepatitis B vaccine according to the record After confirming the vaccines and having the mother sign the consent form, the MA administered the Hepatitis B vaccine. The mother then gave the MA her personal vaccine record for her to fill out the new vaccines on. It was at this point that the MA noticed that  the patient had already received 3 doses in the series for Hepatitis B and that she accidentally just gave her a 4th dose. MA reported it to me, her supervisor immediately. We explained to the mother that she had received an additional dose of the vaccine and to let us know if she had any reactions or symptoms within the next few days. Mother said okay, confirming to us her understanding. Patient left our clinic  with no signs/symptoms of any adverse affects or events.
after 2nd covid vaccination (2 weeks after) patients legs swelled up significantly. from her waist down is "inflamed" Also  states tiredness.
9:45 PM experienced extreme pain at site and headache. Fever 99 degrees. Extreme shivering - freezing, teeth chattering - uncontrollable vomiting x 4. Took TYLENOL ex strength; heating pad, ice next day very tired.
Woke up with fever, chills, muscle aches, joint pain, headache, fatigue. Nausea, loss of appetite. treated with Tylenol which controlled fever. Slept a lot.
Approximately 5 days later I  began having symptoms which then developed into a shingles rash on the 7th day after receiving the vaccine. I wanted to report this to see if others had the same experience.
Rash, NauseaVomiting, CHEST PAIN, LEFT ARM "NERVE PAIN", REDNESS LEFT ARM Narrative:
I have thoracic back pain that started after a physical therapist pushed on my back doing a spinal mobilization on 2/8/21. I had my COVID vaccine in the morning and my physical therapy appointment in the afternoon. The pain started after my PT appointment. After a myofascial release massage on 5/26/21, I have had neck pain and a headache. Both of these conditions have been described as musculoskeletal problems. Overall the back pain has improved. My neck pain and headache have not improved. I have had a lot of muscle tightness and anxiety. I also hadn't worked out a lot so I think my muscles weren't as strong as they should be.
patient felt fatigued the afternoon/evening of the vaccination date. went to bed. woke up at 3:00 am due to severe palpitations. palpitations continued, patient  presented to clinic with continued palpitations, fatigue, tachycardia, and proceeded to get a headache
Tingling of lips and cheeks that started about 20 minutes after the injection and lasted for about 2 hours.  No treatment necessary.
Approximately one month after recieving my second dose of the vaccination, I began menstruating every week. I have the Mirena ring placed and typically don't get my period so this was a significant change for me. Along with the periods, I also got a bad case of cystic acne along my jawline and neck. This lasted until the end of May when my periods are now back to usual and the acne has resolved after using some Clindamycin.
I developed a minor rash over my entire body. This rash was significantly exacerbated whenever my skin was contacted by anything. Compression or tight fitting  clothing was particularly problematic. The rash wasn't painful, but was itchy. Because it wasn't painful or overly concerning, I did not see a healthcare provider about it. I used an OTC hydrocortisone cream several times per week. The rash lasted approximately two months before subsiding. I had not experienced a rash like this before in my life, so I strongly believe it was a side effect of the vaccine. It should be noted that this was my third series of the vaccine, and I didn't develop this rash from the first two series.
24 hrs later devel cyanotic, swollen leg x 6 degrees; resolved spontaneously w/residual problems;